The Autoimmune Liver Disease Symposium

The Autoimmune Liver Disease Symposium

June 2, 2023 — Toronto, Ont.

Hilton Toronto Airport Hotel & Suites — 5875 Airport Road, Mississauga, Ont. — (905) 677-9900

CHAIRED BY DR. GIDEON HIRSCHFIELD TORONTO CENTRE FOR LIVER DISEASE

A Primer for Practicing Physicians

A unique event for physicians and other health care professionals to gain valuable insights from internationally recognized experts

 

Registration administered by the Canadian PBC Society

SYMPOSIUM REGISTRATION FEE

Regular: $175 Clinical Fellow: $75

Symposium fee includes:
  • Admission to all sessions
  • Lunch + light refreshments throughout the day
  • Meet & greet reception
  • Special Canadian PBC Society group hotel rate of $199
  • Free shuttle service to and from Toronto Pearson airport and the hotel
  • Special daily parking rate of $18
  • Free WiFi

BOOK HOTEL

Hilton Toronto Airport Hotel & Suites 5875 Airport Road, Mississauga, Ontario Directly across from Pearson International Airport. Free shuttle service between airport and hotel.


$199 special Canadian PBC Society room rate — guaranteed for bookings made before May 11th. Book directly with Hilton Toronto Airport Hotel & Suites 1-800-HILTONS (Use Group Discount Code CPBC23) OR Quick and Easy Online Reservation

FRIDAY, JUNE 2

9:30 – 10:00 AM

Registration and light refreshments

10:00 – 10:05

Introduction by Dr. Aliya Gulamhusein, (Toronto)

Morning Chairs: Dr. Mark Swain (Calgary) & Dr. Inbal Houri (Toronto

10:05 – 10:35

“Unravelling the cellular basis of immune mediated liver disease ” Dr Sonya MacParland (Toronto)

10:35 – 11:05

“Grand rounds in autoimmune liver disease: Part I”. Fellow from Edmonton (Supervisor Dr Andy Mason)

11:05 – 11:35

“Primary biliary cholangitis- care pathways and state-of-the art care” Dr G Hirschfield (Toronto)

11:35 – 12:00

Visiting lecture: Dr Cynthia Levy (Miami): “Itch and beyond-symptom led care in PBC”

12:00 – 12:45

Lunch

Afternoon Chairs: Dr. Andy Mason (Edmonton) & Dr. Kristel Leung (Toronto)

12:45 – 1:15

“Autoimmune hepatitis- PBC Overlap syndromes: reality or fiction?”  Dr Aldo Montano-Loza (Edmonton)

1:15 – 1:45

“Grand rounds in autoimmune liver disease: Part II”. Fellow from Vancouver (Supervisor Dr Hin Hin Ko)

1:45 – 2:15

“Managing bone disease and hyperlipidemia in PBC- where are we at?”  Dr Magnus McLeod (Halifax)

2:15 – 2:45

“Portal hypertensive complications of cholestatic liver disease” Dr Hin Hin Ko (Vancouver)

2:45 – 3:15

Coffee

Chair: Dr. Cynthia Levy (Miami)

3:15 – 3:45

“Is histology under utilised in PBC care?” Dr Julian Hercun (Montreal)

3:45 – 4:00

Conclusions: “Looking to the future and our next 25 years”  PBC Dr Mark Swain (Calgary)

4:00

Meet and Greet Reception

PROGRAM HIGHLIGHTS

  • The latest developments in autoimmune liver disease diagnosis, treatment and research
  • Updates on the current management of autoimmune liver disease
  • Highlights of developments in new science and emerging therapies
  • An excellent continuing education opportunity for all

 

ABOUT THE SPEAKERS

  • Dr. Aliya Gulamhusein, MD, MPH FRCPC. Assistant Professor and Clinical Investigator, in the Division of Gastroenterology at the University of Toronto.  Dr. Gulamhusein is co-lead of the Autoimmune Liver Disease Clinic, a dedicated program focused on optimizing care for patients with PBC, PSC, and autoimmune hepatitis,  at the Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network.
     
  •  
  • Dr. Julian Hercun completed his medical training as well as his Internal Medicine and Gastroenterology fellowship at the Université de Montreal. After completing additional training at the Liver Diseases Branch of the National Institute of Diabetes, Digestive and Kidney Diseases he joined the Liver Unit of the Centre Hospitalier de l’Université de Montréal (CHUM) in 2021. His clinical and research interest include auto-immune liver disease as well as hepatic involvement in systemic diseases.
  •  
  •  
  • Dr. Gideon Hirschfield is a world-renowned autoimmune liver disease clinician and researcher, and he has extensive clinical expertise in the management of complex liver disease, pre- and post-transplant. He was recently awarded the inaugural Lily and Terry Horner Chair in Autoimmune Liver Disease Research at UHN’s Toronto Centre for Liver Disease and is leading the Centre’s Autoimmune Liver Disease program along with Dr. Aliya Gulamhusein. This comprehensive program offers life-long care to patients with autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis, while advancing groundbreaking research.

 

  • Dr. Inbal Houri

     attended the Hebrew University of Jerusalem and joined the Toronto Center for Liver Disease in July of 2022. Dr. Houri is currently completing a fellowship in advanced autoimmune liver disease, where she is undertaking several research projects studying quality of life, as well as variant and overlap syndromes.

  • Dr. Hin Hin Ko is a Clinical Associate Professor affiliated with the UBC Division of Gastroenterology. She is part of the Pacific Gastroenterology Associates and based at St. Paul’ Hospital. She completed her medical degree at the University of Toronto, Internal Medicine residency and Gastroenterology fellowship at UBC.  In addition, she completed a year of fellowship in Hepatology and Nutrition at the University of Toronto.  She has special interests in viral hepatitis, autoimmune liver diseases and fatty liver disease.  Besides clinical work, she also does clinical research and teaching.


  • Dr Kristel Leung attended medical school at the University of British Columbia, and first joined the Toronto Center for liver disease in 2018 as a research associate and Gastroenterology fellow. At present sheis a hepatology fellow with the Toronto Center for Liver Disease, and also completing her PhD in clinical epidemiology. Dr. Leung recently received thDr. KN Jeejeebhoy Award for Excellence in Gastroenterology in 2021, for the most outstanding graduating gastroenterology resident in both clinical and research capacity. She has a strong interest in the epidemiology of autoimmune liver diseases in Ontario and how the environment can influence disease pathology and trajectory.
  •  
  •  
  • Dr Cynthia Levy attended Medical school at the Universidade Federal do Rio de Janeiro in Brazil. Following the completion of her residency in Brazil, she attended the University of Miami for further training. After completing training in both Miami and at the Mayo clinic in Minnesota, Dr. Levy was awarded the AASLD’s Advanced Hepatology Fellowship to train for one year at the University of Florida in Gainesville.  Dr. Levy was presented with the Arthur Hertz Chair in Liver Diseases at the University of Miami Miller School of Medicine in June of 2019. Her current research is focused on rare cholestatic diseases such as PSC and PBC. 
  •  
  •  
  • Dr. Sonya MacParland is currently an assistant professor at the University of Toronto in the department of Laboratory and Pathobiology. She is also a Senior Scientist and Immunologist in the Toronto General Hospital’s Soham & Shaila Ajmera Family Transplant Centre.  Her research in primarily focused on using advanced genomics to describe the microenvironment of both healthy and diseased livers. Her team has developed the first transcriptomic map of the human liver as a platform to investigate how immune dysregulation influences liver diseases.
  •  
  •  
  • Dr. Andy Mason is a Professor of Medicine and an Alberta Heritage Foundation for Medical Research Senior Scholar. He trained at the Liver Unit, Kings College Hospital, in London, England and then moved to Washington University, St. Louis as a Gastroenterology Fellow to train in molecular virology. At Ochsner Clinic Foundation, New Orleans he became the Medical Director of Liver Transplantation and an Assistant Professor in the Department of Medicine, Tulane University Medical Center. He relocated to the University of Alberta in 2002 and is currently the Director Research for the Division of Gastroenterology and Director of The Applied Genomics Centre.
  •  
  •  
  • Dr. Magnus McLeod

     is an assistant professor in the Division of General Internal Medicine at Dalhousie University. As an internist, he has a strong clinical and academic interest in liver disease, particularly PBC and fatty liver disease.
  •  

  • Dr. Aldo Montano-Loza obtained his undergraduate training at the Universidad de Guadalajara, in Mexico, where he graduated with an MD degree in 1998.  Then, he completed his Internal Medicine residency and Gastroenterology & Endoscopy training at the Instituto Nacional de Ciencias Medicas y Nutricion, in 2005, and obtained a Master Degree in Medical Science at the Universidad Autonoma de Mexico.  He obtained further training in Autoimmune Liver Diseases under the mentorship of Dr. Albert J. Czaja at the Mayo Clinic in Rochester Minnesota in 2008, and in 2009, he finished another Fellowship in Advanced Hepatology and Liver Transplantation at the University of Alberta.  He obtained his PhD in Medical Science in 2013. He was the recipient of the International Travel Training Grant from the American College of Gastroenterology in 2006, the Clinical Research Awards from the American College of Gastroenterology in 2011 and 2018, the Canadian National Transplant Research Program Innovation Grant Award in 2018 and the Canadian Liver Foundation designated liver transplant research grant for 2019.

 

  • Dr. Mark Swain has

     been a practicing hepatologist and clinician-scientist since his arrival in Alberta in 1993. He is a leader in the University of Calgary’s Division of Gastroenterology and Hepatology and holding the Cal Wenzel Family Foundation Chair in Hepatology (a research chair) and Head, Translational Research Core, Snyder Institute of Chronic Diseases. He is widely published in the areas of liver disease and autoimmunity with more than 110 peer-reviewed articles published to date.